Venkat Reddy

Dr. Reddy joined Macrophage Pharma in January 2020 with over 15 years of experience in the biopharmaceutical industry. He was previously at Glenmark Pharmaceuticals where he was a senior vice president and global head of translational sciences leading the translational programs of the Company’s innovative preclinical and clinical portfolio. He co-founded APC Therapeutics Inc., a small molecule immuno-oncology startup, the lead program of which was licensed to Glenmark. Previously, Dr. Reddy acted as a senior director of strategic partnerships at Pfizer’s Center for Therapeutic Innovation.

Prior to that, he held roles with Sanofi, as head of bio-innovation and as global head of oncology target discovery where he was involved in target identification and validation (TIDVAL) function and progression of multiple programs from preclinical to clinical trials. Before joining Sanofi, Dr. Reddy was a group leader in oncology drug discovery at the Novartis Institute for Functional Genomics, San Diego. He received his Ph.D. in human biology at Ludwig Maximilians Universität, Munich, and completed a post-doctoral fellowship in oncology and immunology at Scripps Research Institute, La Jolla.